Heyholder
‹ Activism Filings

BiotoxtechCo.,Ltd. Periodic Report

BiotoxtechCo.,Ltd.

AI summary · Not investment advice

Biotoxtech sold KRW 16.1 billion in Q3 and earned KRW 0.6 billion from its main business, turning to a profit from a loss a year earlier.

Operating profit · 3 months

KRW 579.0 million

Key facts

Revenue (3 months)
KRW 16.1 billion
Net income (3 months)
KRW -1.3 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 11.9 billion
Revenue (year to date)
KRW 42.4 billion
Operating profit (prior-year 3 months)
KRW -1.4 billionLoss
Operating profit (year to date)
KRW -1.4 billionLoss
Net income (prior-year 3 months)
KRW 4.5 billion
Net income (year to date)
KRW -10.9 billionLoss

Commentary

AI commentary · Not investment advice

What happened

Biotoxtech reported its consolidated results for the third quarter of 2026 (July to September). Sales for the 3 months were KRW 16.06 billion. That is 35.0% more than the same 3 months a year earlier (KRW 11.90 billion), and 11.1% more than the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was KRW 579 million. A year earlier, the same period had an operating loss of KRW 1.36 billion. So the core business turned profitable again, and it also turned profitable compared with the previous quarter.

What changes for shareholders

Net income (the final profit after taxes and all other items) for the 3 months was a loss of KRW 1.28 billion. A year earlier, the same period had a net income of KRW 4.46 billion, so the result turned to a loss.

For the year to date (January 1 to September 30), sales were KRW 42.39 billion. Operating profit was a loss of KRW 1.42 billion. Net income was a loss of KRW 10.89 billion.

Comments

No comments yet

Comments from shareholders will appear here.